Apeiron Biologics (dinutuximab beta) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Apeiron Biologics (dinutuximab beta) General Information
Description
A global commercialization rights to the oncology product Isqette (dinutuximab beta). Dinutuximab beta is currently used as part of the regimen for the treatment of high risk neuroblastoma in Europe and is available under a managed access program.
Contact Information
Corporate Office
- Vienna
- Austria
Corporate Office
- Vienna
- Austria
Apeiron Biologics (dinutuximab beta) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Apeiron Biologics (dinutuximab beta) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Apeiron Biologics (dinutuximab beta) FAQs
-
Where is Apeiron Biologics (dinutuximab beta) headquartered?
Apeiron Biologics (dinutuximab beta) is headquartered in Vienna, Austria.
-
What industry is Apeiron Biologics (dinutuximab beta) in?
Apeiron Biologics (dinutuximab beta)’s primary industry is Buildings and Property.
-
Is Apeiron Biologics (dinutuximab beta) a private or public company?
Apeiron Biologics (dinutuximab beta) is a Private company.
-
What is Apeiron Biologics (dinutuximab beta)’s current revenue?
The current revenue for Apeiron Biologics (dinutuximab beta) is .
-
Who are Apeiron Biologics (dinutuximab beta)’s investors?
APEIRON Biologics has invested in Apeiron Biologics (dinutuximab beta).
-
When was Apeiron Biologics (dinutuximab beta) acquired?
Apeiron Biologics (dinutuximab beta) was acquired on 04-Oct-2016.
-
Who acquired Apeiron Biologics (dinutuximab beta)?
Apeiron Biologics (dinutuximab beta) was acquired by EUSA Pharma (UK).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process